These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17631971)

  • 21. Systemic and compartmentalized immune response in canine visceral leishmaniasis.
    Reis AB; Martins-Filho OA; Teixeira-Carvalho A; Giunchetti RC; Carneiro CM; Mayrink W; Tafuri WL; Corrêa-Oliveira R
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):87-95. PubMed ID: 19054576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs.
    Mettler M; Grimm F; Capelli G; Camp H; Deplazes P
    J Clin Microbiol; 2005 Nov; 43(11):5515-9. PubMed ID: 16272479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, parasitologic, and immunologic evolution in dogs experimentally infected with sand fly-derived Leishmania chagasi promastigotes.
    Travi BL; Osorio EY; Saldarriaga OA; Cadena H; Tabares CJ; Peniche A; Lee S; Melby PC
    Am J Trop Med Hyg; 2009 Dec; 81(6):994-1003. PubMed ID: 19996427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers.
    Carrera L; Fermín ML; Tesouro M; García P; Rollán E; González JL; Méndez S; Cuquerella M; Alunda JM
    Exp Parasitol; 1996 Mar; 82(2):139-46. PubMed ID: 8617340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.
    Quinnell RJ; Courtenay O; Garcez LM; Kaye PM; Shaw MA; Dye C; Day MJ
    Vet Immunol Immunopathol; 2003 Feb; 91(3-4):161-8. PubMed ID: 12586479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.
    Rafati S; Nakhaee A; Taheri T; Taslimi Y; Darabi H; Eravani D; Sanos S; Kaye P; Taghikhani M; Jamshidi S; Rad MA
    Vaccine; 2005 May; 23(28):3716-25. PubMed ID: 15882533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of anti-platelet IgM and IgG antibodies in dogs naturally infected by Leishmania infantum.
    Terrazzano G; Cortese L; Piantedosi D; Zappacosta S; Di Loria A; Santoro D; Ruggiero G; Ciaramella P
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):331-7. PubMed ID: 16406554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of anti-platelet antibodies in dogs naturally co-infected by Leishmania infantum and Ehrlichia canis.
    Cortese L; Terrazzano G; Piantedosi D; Sica M; Prisco M; Ruggiero G; Ciaramella P
    Vet J; 2011 Apr; 188(1):118-21. PubMed ID: 20456989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between specific antibody responses and clinical signs of dogs living in Tunisian endemic areas of canine leishmaniasis caused by Leishmania infantum.
    Mhadhbi M; Chaabouni A; Bouabid C; Sassi A
    Acta Trop; 2021 Jun; 218():105906. PubMed ID: 33775627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profile of anti-Leishmania antibodies related to clinical picture in canine visceral leishmaniasis.
    de Freitas JC; Lopes-Neto BE; de Abreu CR; Coura-Vital W; Braga SL; Reis AB; Nunes-Pinheiro DC
    Res Vet Sci; 2012 Oct; 93(2):705-9. PubMed ID: 22226072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications.
    Cordeiro-da-Silva A; Cardoso L; Araújo N; Castro H; Tomás A; Rodrigues M; Cabral M; Vergnes B; Sereno D; Ouaissi A
    Immunol Lett; 2003 Apr; 86(2):155-62. PubMed ID: 12644317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
    Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
    Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis.
    de Oliveira Mendes C; Paraguai de Souza E; Borja-Cabrera GP; Maria Melo Batista L; Aparecida dos Santos M; Ellner Parra L; Menz I; Palatnik M; Palatnik de Sousa CB
    Vaccine; 2003 Jun; 21(19-20):2589-97. PubMed ID: 12744895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis.
    Morales G; Carrillo G; Requena JM; Guzman F; Gomez LC; Patarroyo ME; Alonso C
    Parasitology; 1997 Jun; 114 ( Pt 6)():507-16. PubMed ID: 9172421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
    Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
    Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs.
    Daneshvar H; Molaei MM; Afshar RM; Kamiabi H; Burchmore R; Hagan P; Phillips RS
    Vet Immunol Immunopathol; 2009 May; 129(1-2):28-35. PubMed ID: 19147233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic components of partially purified antigens of Leishmania donovani infantum recognized by sera from dogs with asymptomatic or active visceral leishmaniasis.
    Da Costa JM; Neogy AB; Vouldoukis I; Silva ML; Gentilini M; Monjour L
    Am J Trop Med Hyg; 1996 Nov; 55(5):511-5. PubMed ID: 8940982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
    Gradoni L; Foglia Manzillo V; Pagano A; Piantedosi D; De Luna R; Gramiccia M; Scalone A; Di Muccio T; Oliva G
    Vaccine; 2005 Nov; 23(45):5245-51. PubMed ID: 16054272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel exo-antigen-based ELISA for the detection of canine leishmaniasis.
    Rajasekariah GH; Cardoso L; Dogcio DA; Martin SK; Smithyman AM
    Am J Trop Med Hyg; 2008 Apr; 78(4):616-23. PubMed ID: 18385358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological and immunohistochemical study of type 3 complement receptors (CD11b/CD18) in livers and spleens of asymptomatic and symptomatic dogs naturally infected with Leishmania (Leishmania) chagasi.
    Lima WG; Oliveira PS; Caliari MV; Gonçalves R; Michalick MS; Melo MN; Tafuri WL; Tafuri WL
    Vet Immunol Immunopathol; 2007 May; 117(1-2):129-36. PubMed ID: 17383741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.